Axela Biosensors provides protein detection, characterization and monitoring products used in life science, health and clinical research. Our proprietary Diffractive Optics Technology (dot™), is based on research techniques initially developed at the University of Toronto and is a novel, patented combination of two robust, well-understood technologies: grating-based light diffraction and immobilized capture surfaces. This unique combination produces a simple, highly sensitive, cost-effective platform for measuring protein levels and characterizing their interactions in real-time without labels. This capability makes the dotLab™ System the only protein-characterization platform that can be used at each stage of the assay development process, removing many of the obstacles associated with traditional end-point multiplex analysis. It allows researchers to rapidly move biomarker discoveries through the reagent qualification and assay development process into routine use.
About
Details
- Annual revenue
- $700000
Products & services in Toronto
Keywords
Based light diffraction
Point multiplex analysis
Similar companies nearby
- Immunodeficiency Canada 0.1 mi 439 University Ave, suite 848, Toronto
- Centre for Global Ehealth Innovation 0.2 mi 190 Elizabeth St Fl 4, Toronto
- Atuka Ltd 0.4 mi 101 College St Suite 120, Toronto
- Sterling Life Sciences 0.3 mi 425 University Avenue Eighth Floor, Toronto
- MM Venture Partners 0.3 mi 95 Wellington Street West 22nd Floor, Toronto